1. Home
  2. REBN vs SLXN Comparison

REBN vs SLXN Comparison

Compare REBN & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REBN
  • SLXN
  • Stock Information
  • Founded
  • REBN 2015
  • SLXN 2008
  • Country
  • REBN United States
  • SLXN Israel
  • Employees
  • REBN N/A
  • SLXN N/A
  • Industry
  • REBN Restaurants
  • SLXN
  • Sector
  • REBN Consumer Discretionary
  • SLXN
  • Exchange
  • REBN Nasdaq
  • SLXN NYSE
  • Market Cap
  • REBN 13.5M
  • SLXN 7.3M
  • IPO Year
  • REBN 2022
  • SLXN N/A
  • Fundamental
  • Price
  • REBN $2.79
  • SLXN $0.80
  • Analyst Decision
  • REBN
  • SLXN Strong Buy
  • Analyst Count
  • REBN 0
  • SLXN 1
  • Target Price
  • REBN N/A
  • SLXN $5.00
  • AVG Volume (30 Days)
  • REBN 60.7K
  • SLXN 141.1K
  • Earning Date
  • REBN 08-18-2025
  • SLXN 08-21-2025
  • Dividend Yield
  • REBN N/A
  • SLXN N/A
  • EPS Growth
  • REBN N/A
  • SLXN N/A
  • EPS
  • REBN N/A
  • SLXN N/A
  • Revenue
  • REBN $6,103,732.00
  • SLXN N/A
  • Revenue This Year
  • REBN $335.98
  • SLXN N/A
  • Revenue Next Year
  • REBN N/A
  • SLXN N/A
  • P/E Ratio
  • REBN N/A
  • SLXN N/A
  • Revenue Growth
  • REBN 3.38
  • SLXN N/A
  • 52 Week Low
  • REBN $1.03
  • SLXN $0.58
  • 52 Week High
  • REBN $8.30
  • SLXN $41.85
  • Technical
  • Relative Strength Index (RSI)
  • REBN 55.87
  • SLXN N/A
  • Support Level
  • REBN $2.37
  • SLXN N/A
  • Resistance Level
  • REBN $3.00
  • SLXN N/A
  • Average True Range (ATR)
  • REBN 0.17
  • SLXN 0.00
  • MACD
  • REBN 0.04
  • SLXN 0.00
  • Stochastic Oscillator
  • REBN 61.41
  • SLXN 0.00

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

Share on Social Networks: